Search

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period from 14-20 July 2019 and includes updates on chikungunya virus disease and dengue, measles, Ebola virus disease, monitoring the environmental sustainability of Vibrio growth in the Baltic Sea and West Nile virus infection.

This is the fifth update of a rapid risk assessment originally produced on 9 August 2018. This rapid risk assessment addresses the potential public health impact of Ebola virus disease for EU/EEA countries and assesses the likelihood of international expansion.

The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period from 30 June-6 July 2019 and includes updates on polio, Ebola virus disease, Vibrio, West Nile virus infection and acute neurological syndrome in Peru.

In 2019, the hajj will take place between 9 and 14 August. The risk for EU/EEA citizens to become infected with communicable diseases during the 2019 hajj is considered low, thanks to the vaccination requirements for travelling to Makkah (Mecca) and the Saudi Arabian preparedness plans that address the management of health hazards during and after hajj.

This report covers the events and threats detected by the ECDC epidemic intelligence (EI) team in 2018 and the actions taken related to these findings.

This issue of the ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats covers the period from 23-29 June 2019 and includes updates on chikungunya and dengue, Ebola virus disease, monitoring the environmental suitability of Vibrio growth in the Baltic Sea, West Nile virus infection, suspected cases of chikungunya virus disease not confirmed by further testing in Spain and acute neurological syndrome in Peru.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period from 16-22 June 2019 and includes updates on Ebola virus disease, West Nile virus infection, chikungunya virus disease and acute neurological syndrome in Peru.

This update of the risk assessment ‘Dengue outbreak in Réunion, France’ published on 5 July 2018, has been triggered by the significant size of the outbreak and its expected duration, which is anticipated to overlap with high vector activity in the southern EU.

In April 2019, Finland reported false-negative or equivocal results in patients tested for Chlamydia trachomatis (CT) using Aptima Combo 2 Assay (Hologic) (AC2).